NewAmsterdam Pharma Co. NV (NAMS)
27.34
+0.49
(+1.82%)
USD |
NASDAQ |
Aug 25, 16:00
27.34
0.00 (0.00%)
After-Hours: 19:59
NewAmsterdam Pharma Total Assets (Quarterly) : 704.45M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 704.45M |
| March 31, 2026 | 732.64M |
| December 31, 2025 | 769.28M |
| September 30, 2025 | 786.43M |
| June 30, 2025 | 815.11M |
| March 31, 2025 | 818.41M |
| December 31, 2024 | 864.62M |
| September 30, 2024 | 439.19M |
| June 30, 2024 | 446.69M |
| Date | Value |
|---|---|
| March 31, 2024 | 488.46M |
| September 30, 2022 | 139.28M |
| June 30, 2022 | 138.90M |
| March 31, 2022 | 139.06M |
| December 31, 2021 | 139.51M |
| September 30, 2021 | 138.98M |
| June 30, 2021 | 139.22M |
| March 31, 2021 | 139.64M |
| December 31, 2020 | 139.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ProQR Therapeutics NV | 152.69M |
| Pharming Group NV | 467.98M |
| argenx SE | -- |
| Arcutis Biotherapeutics, Inc. | 488.54M |
| Damora Therapeutics, Inc. | 543.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 73.03M |
| Shareholders Equity (Quarterly) | 631.42M |
| Debt to Equity Ratio | 0.0001 |
| Current Ratio | 9.034 |
| Net Debt Paydown Yield | 0.00% |